Integrated Investment Consultants LLC lowered its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 84.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,097 shares of the company's stock after selling 21,469 shares during the period. Integrated Investment Consultants LLC's holdings in Colgate-Palmolive were worth $384,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Geode Capital Management LLC lifted its position in Colgate-Palmolive by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 20,518,014 shares of the company's stock valued at $1,868,723,000 after buying an additional 324,683 shares during the period. Northern Trust Corp lifted its position in Colgate-Palmolive by 11.7% during the fourth quarter. Northern Trust Corp now owns 9,497,819 shares of the company's stock valued at $863,447,000 after buying an additional 993,328 shares during the period. Deutsche Bank AG lifted its position in Colgate-Palmolive by 35.6% during the fourth quarter. Deutsche Bank AG now owns 6,922,994 shares of the company's stock valued at $629,369,000 after buying an additional 1,816,865 shares during the period. Ameriprise Financial Inc. lifted its position in Colgate-Palmolive by 3.8% during the fourth quarter. Ameriprise Financial Inc. now owns 6,798,821 shares of the company's stock valued at $617,359,000 after buying an additional 246,908 shares during the period. Finally, Invesco Ltd. lifted its position in Colgate-Palmolive by 2.7% during the fourth quarter. Invesco Ltd. now owns 6,537,918 shares of the company's stock valued at $594,362,000 after buying an additional 169,140 shares during the period. Institutional investors own 80.41% of the company's stock.
Analyst Upgrades and Downgrades
CL has been the subject of several recent research reports. Citigroup raised their price objective on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research report on Monday, April 28th. UBS Group lowered their price objective on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a research report on Thursday, July 17th. Wells Fargo & Company raised their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a research report on Wednesday, April 2nd. Barclays lifted their price target on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Finally, Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $100.77.
View Our Latest Analysis on Colgate-Palmolive
Colgate-Palmolive Price Performance
NYSE CL opened at $87.93 on Friday. Colgate-Palmolive Company has a one year low of $85.32 and a one year high of $109.30. The stock has a 50-day moving average of $90.24 and a 200 day moving average of $90.37. The company has a market capitalization of $71.26 billion, a price-to-earnings ratio of 24.84, a PEG ratio of 4.53 and a beta of 0.37. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85.
Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The company had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.92 billion. During the same period last year, the company earned $0.86 EPS. Colgate-Palmolive's revenue for the quarter was down 3.0% on a year-over-year basis. On average, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.
Colgate-Palmolive Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 annualized dividend and a yield of 2.37%. Colgate-Palmolive's payout ratio is 58.76%.
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.